We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
(+8.7%)
Cap. Flow
+$4.56B
Cap. Flow
% of AUM
5.05%
Top 10 Holdings %
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$526M |
| 2 |
US Bancorp
USB
|
+$301M |
| 3 |
Pultegroup
PHM
|
+$217M |
| 4 |
BATS
Bats Global Markets, Inc.
BATS
|
+$145M |
| 5 |
Charter Communications
CHTR
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARG
Airgas Inc
ARG
|
+$477M |
| 2 |
Pfizer
PFE
|
+$305M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$294M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$275M |
| 5 |
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.61% |
| 2 | Technology | 10.97% |
| 3 | Healthcare | 10.51% |
| 4 | Consumer Discretionary | 7.19% |
| 5 | Industrials | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Park Aerospace
PKE
$720M
| $416K | ﹤0.01% |
28,692
+11,174
| +64% | +$177K |
|
3352
National Presto Industries
NPK
$870M
| $413K | ﹤0.01% |
4,386
+1,447
| +49% | +$127K |
|
|
BSTC
3353
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $411K | ﹤0.01% |
10,279
+4,090
| +66% | +$150K |
|
|
NORD
3354
DELISTED
Nord Anglia Education, Inc.
NORD
| $411K | ﹤0.01% |
+19,402
| New | +$419K |
|
3355
Extreme Networks
EXTR
$3.8B
| $410K | ﹤0.01% |
121,150
+33,681
| +39% | +$115K |
|
3356
Harmony Gold Mining
HMY
$9.7B
| $410K | ﹤0.01% |
113,473
+23,284
| +26% | +$80.5K |
|
|
SP
3357
DELISTED
SP Plus Corporation
SP
| $410K | ﹤0.01% |
18,167
+6,521
| +56% | +$146K |
|
|
BRFS
3358
DELISTED
BRF SA
BRFS
| $409K | ﹤0.01% |
29,393
-319,924
| -92% | -$4.3M |
|
3359
Lifecore Biomedical
LFCR
$162M
| $409K | ﹤0.01% |
37,959
-4,130
| -10% | -$45.6K |
|
3360
Rockwell Medical
RMTI
$27.2M
| $409K | ﹤0.01% |
490
+170
| +53% | +$158K |
|
|
TOUR
3361
Tuniu
TOUR
$56.2M
| $409K | ﹤0.01% |
4,849
+581
| +14% | +$55.9K |
|
3362
Accuray
ARAY
$27.5M
| $408K | ﹤0.01% |
78,472
-16,003
| -17% | -$87.4K |
|
|
XCRA
3363
DELISTED
Xcerra Corporation
XCRA
| $408K | ﹤0.01% |
71,014
+21,514
| +43% | +$132K |
|
|
DTSI
3364
DELISTED
DTS, Inc.
DTSI
| $408K | ﹤0.01% |
15,412
+5,807
| +60% | +$138K |
|
|
KDNY
3365
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $406K | ﹤0.01% |
7,189
-3,348
| -32% | -$203K |
|
3366
Intrepid Potash
IPI
$476M
| $404K | ﹤0.01% |
28,093
+23,614
| +527% | +$298K |
|
3367
Par Pacific Holdings
PARR
$4.17B
| $404K | ﹤0.01% |
+26,290
| New | +$449K |
|
3368
Alpha and Omega Semiconductor
AOSL
$829M
| $403K | ﹤0.01% |
28,947
-23,885
| -45% | -$321K |
|
3369
IDT Corp
IDT
$1.67B
| $402K | ﹤0.01% |
33,454
+10,330
| +45% | +$114K |
|
|
FMI
3370
DELISTED
Foundation Medicine, Inc.
FMI
| $401K | ﹤0.01% |
+21,493
| New | +$388K |
|
3371
Sixth Street Specialty
TSLX
$1.67B
| $399K | ﹤0.01% |
+24,036
| New | +$393K |
|
3372
StoneX
SNEX
$8.72B
| $398K | ﹤0.01% |
73,725
-21,450
| -23% | -$114K |
|
3373
Metallus
MTUS
$833M
| $397K | ﹤0.01% |
41,160
-4,710
| -10% | -$49.1K |
|
|
HDP
3374
DELISTED
Hortonworks, Inc.
HDP
| $397K | ﹤0.01% |
37,164
-51,741
| -58% | -$584K |
|
3375
Park-Ohio Holdings
PKOH
$550M
| $396K | ﹤0.01% |
13,990
+5,838
| +72% | +$188K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2016 Portfolio in Review
As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.
- Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
- Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
- Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
- Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
- Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
- Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.
Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.